Cardiovascular risk, fatty liver disease, glucose and insulin curve among prediabetes phenotypes in Peruvian population
- PMID: 39035828
- PMCID: PMC11256264
- DOI: 10.1016/j.ajmo.2022.100007
Cardiovascular risk, fatty liver disease, glucose and insulin curve among prediabetes phenotypes in Peruvian population
Abstract
Aims: To describe the cardiovascular risks, fatty liver disease, and glucose and insulin curve among prediabetes phenotypes (PPh) in Peruvian population.
Methods: A study was carried out using a secondary database of a series of patients with identified risk factors for diabetes mellitus type 2 in one clinic in Lima, Peru. Patients were divided according with the OGTT in impaired glucose 2h or IGT(Pph1), impaired fasting glucose or IFG(Pph3) or both(Pph2).
Results: 259 patients were identified for analysis, 149 of whom had normal OGTT, 94 had prediabetes (36.3%), and 16 diabetes (6.2%). We found that 37(39.4%), 37(39.4%) and 20(21.2%) presented Pph1, Pph-2 and Pph-3 respectively. Most of the cardiovascular risks and hepatic function comparison showed no difference in our study sample groups. However, we found that Pph2 showed significantly higher abnormalities in HDL-c, triglycerides, hepatic steatosis, and HOMA-IR compared with normal OGTT group (p < 0.05). Interestingly, this difference was not seen with the other phenotypes. Also, hepatic steatosis was higher in Pph2 compared to Pph3 (p < 0.05). HOMA-IR was high in Phenotype 2 compared with Phenotype 1. Regarding hepatic steatosis, this was high in all prediabetes phenotypes, however we found this to be of statistical significance in Pph2 compared to Pph3 (p < 0.01).
Conclusions: In general, prediabetes phenotypes show a similar association with cardiovascular risk factors and hepatic steatosis, however, Pph2 show more differences in specific comparisons. We believe that this study is a starting point for further investigation to understand prediabetes in Peruvian population and be able to improve disease risk stratification.
© 2022 The Authors.
Figures
Similar articles
-
Association of hepatic steatosis derived from ultrasound and quantitative MRI with prediabetes in the general population.Sci Rep. 2021 Jun 24;11(1):13276. doi: 10.1038/s41598-021-92681-3. Sci Rep. 2021. PMID: 34168217 Free PMC article.
-
Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.Horm Metab Res. 2017 Feb;49(2):135-141. doi: 10.1055/s-0042-111325. Epub 2016 Jul 26. Horm Metab Res. 2017. PMID: 27459384
-
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):670-6. doi: 10.1016/j.numecd.2014.01.013. Epub 2014 Jan 29. Nutr Metab Cardiovasc Dis. 2014. PMID: 24656139
-
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.Diabet Med. 2002 Sep;19(9):708-23. doi: 10.1046/j.1464-5491.2002.00835.x. Diabet Med. 2002. PMID: 12207806 Review.
-
Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis.BMJ. 2016 Nov 23;355:i5953. doi: 10.1136/bmj.i5953. BMJ. 2016. PMID: 27881363 Free PMC article. Review.
Cited by
-
Prediabetes and Cardiometabolic Risk: The Need for Improved Diagnostic Strategies and Treatment to Prevent Diabetes and Cardiovascular Disease.Biomedicines. 2024 Feb 4;12(2):363. doi: 10.3390/biomedicines12020363. Biomedicines. 2024. PMID: 38397965 Free PMC article. Review.
References
-
- World Health Organization . World Health Organization; Geneva, Switzerland: 2021. Diabetes.
-
- Buysschaert M., Medina J.L., Buysschaert B., Bergman M. Definitions (and current controversies) of diabetes and prediabetes. Curr Diabetes Rev. 2016;12:8–13. - PubMed
-
- Davidson M.B., Kahn RA. A reappraisal of prediabetes. J Clin Endocrinol Metab. 2016;101:2628–2635. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous